Your browser doesn't support javascript.
loading
Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
Miller, William R; Singh, Kavindra V; Arias, Cesar A; Murray, Barbara E.
Affiliation
  • Miller WR; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern Medical School, Houston, Texas, USA William.R.Miller@uth.tmc.edu.
  • Singh KV; Department of Internal Medicine, Division of Infectious Diseases, UTHealth, McGovern Medical School, Houston, Texas, USA.
  • Arias CA; Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern Medical School, Houston, Texas, USA.
  • Murray BE; Department of Internal Medicine, Division of Infectious Diseases, UTHealth, McGovern Medical School, Houston, Texas, USA.
Article in En | MEDLINE | ID: mdl-30150459
ABSTRACT
We tested the ability of clavulanic acid to restore the efficacy of cefazolin against Staphylococcus aureus TX0117, which exhibits the cefazolin inoculum effect (CzIE). In the rat infective endocarditis model, the coadministration of cefazolin plus clavulanic acid resulted in a significant reduction of bacterial counts (7.1 ± 0.5 log10 CFU/g) compared to that with cefazolin alone (2 ± 0.6 log10 CFU/g; P < 0.0001). The addition of a ß-lactamase inhibitor may be a viable strategy for overcoming the CzIE.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Staphylococcal Infections / Staphylococcus aureus / Cefazolin / Clavulanic Acid / Endocarditis / Endocarditis, Bacterial / Methicillin Type of study: Diagnostic_studies Limits: Animals Language: En Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Main subject: Staphylococcal Infections / Staphylococcus aureus / Cefazolin / Clavulanic Acid / Endocarditis / Endocarditis, Bacterial / Methicillin Type of study: Diagnostic_studies Limits: Animals Language: En Year: 2018 Type: Article